Hairy cell leukemia: Epidemiology, pharmacokinetics of cladribine, and long-term follow-up of subcutaneous therapy

Leukemia and Lymphoma

Volumn 52, Issue SUPPL. 2, 2011, Pages 46-49

  Juliusson, Gunnar ^a   Samuelsson, Henrik ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

cladribine; epidemiology; Hairy cell leukemia; long term survival; population based; subcutaneous

Indexed keywords

CLADRIBINE;

ARTICLE; CONTINUOUS INFUSION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; FOLLOW UP; HAIRY CELL LEUKEMIA; HUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL;

CLADRIBINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, HAIRY CELL; MALE; REGISTRIES; SURVIVAL ANALYSIS; SWEDEN;

EID: 79957492280     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.565842     Document Type: Article

References (13)

1. Bouroncle BA, Wiseman BK, Doan CA. Leukemic reticuloendotheliosis. Blood 1958;13:609-630.
2. Quesada JR, Reuben J, Manning JT, Hersh EM, Gutterman JU. Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med 1984;310:15-18. (Pubitemid 14212475)
3. Spiers AS, Parekh SJ. Complete remission in hairy cell leukaemia achieved with pentostatin. Lancet 1984;1:1080-1081. (Pubitemid 14148963)
4. Beutler E. Cladribine (2-chlorodeoxyadenosine). Lancet 1992;340:952-956.
5. Piro LD, Carrera CJ, Carson DA, Beutler E. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990;322:1117-1121. (Pubitemid 20149529)
6. Liliemark J, Juliusson G. On the pharmacokinetics of 2- chloro-20-deoxyadenosine in humans. Cancer Res 1991;51: 5570-5572.
7. Liliemark J, Juliusson G. Cellular pharmacokinetics of 2- chloro-20-deoxyadenosine nucleotides: comparison of intermittent and continuous intravenous infusion and subcutaneous and oral administration in leukemia patients. Clin Cancer Res 1995;1:385-390.
8. Liliemark J, Albertioni F, Hassan M, Juliusson G. On the bioavailability of oral and subcutaneous 2-chloro-20-deoxyadenosine in humans: alternative routes of administration. J Clin Oncol 1992;10:1514-1518. (Pubitemid 23057978)
9. Juliusson G, Heldal D, Hippe E, et al. Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia. J Clin Oncol 1995;13:989-995.
10. Juliusson G, Christiansen I, Hansen MM, et al. Oral cladribine as primary therapy for patients with B-cell chronic lymphocytic leukemia. J Clin Oncol 1996;14:2160-2166. (Pubitemid 26230120)
11. Giovannoni G, Comi G, Cook S, et al. A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. N Engl J Med 2010;362:416-426.
12. Juliusson G, Liliemark J. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-20-deoxyadenosine (CdA): relation to opportunistic infections. Blood 1992;79:888-894.
13. Juliusson G, Lenkei R, Tjonnfjord G, Heldal D, Liliemark J. Low-dose cladribine for symptomatic hairy cell leukaemia. Br J Haematol 1995;89:637-639.